LN≥4
Showing 26 - 50 of >10,000
Colorectal Cancer Trial in Cyprus, United Kingdom (biological, drug, other)
Completed
- Colorectal Cancer
- cetuximab
- +6 more
-
Nicosia, Cyprus
- +24 more
Sep 15, 2021
Cervical Carcinoma Trial in Worldwide (LN-145, LN-145 + pembrolizumab)
Recruiting
- Cervical Carcinoma
- LN-145
- LN-145 + pembrolizumab
-
Phoenix, Arizona
- +39 more
Aug 16, 2022
Lupus or SLE, Nephritis Trial in Assiut (Baricitinib 4 MG, Baricitinib 2 MG, MMF)
Recruiting
- Lupus or SLE
- Nephritis
- Baricitinib 4 MG
- +2 more
-
Assiut, Yes, EgyptManal Hassanien
Jan 13, 2023
Lupus Nephritis Trial in Stockholm (Repeat kidney biopsy)
Recruiting
- Lupus Nephritis
- Repeat kidney biopsy
-
Stockholm, SwedenKarolinska University Hospital
Jun 16, 2022
Malignant Melanoma Trial in Worldwide (UV1, Sargramostim, Ipilimumab)
Recruiting
- Malignant Melanoma
- UV1
- +3 more
-
Phoenix, Arizona
- +39 more
Aug 16, 2022
Systemic Lupus Erythematosus, Lupus Nephritis Trial in Nanjing (Human umbilical cord mesenchymal stem cells, Interleukin-2)
Recruiting
- Systemic Lupus Erythematosus
- Lupus Nephritis
- Human umbilical cord mesenchymal stem cells
- Interleukin-2
-
Nanjing, Jiangsu, ChinaThe Affiliated Nanjing Drum Tower Hospital of Nanjing University
Nov 20, 2022
Lupus Nephritis Trial in Hong Kong (Pre-emptive increase of immunosuppressive treatments, Prednisolone and/or AZA/MMF)
Recruiting
- Lupus Nephritis
- Pre-emptive increase of immunosuppressive treatments
- Prednisolone and/or AZA/MMF
-
Hong Kong, Hong Kong
- +1 more
Jul 25, 2022
Metastatic Melanoma to the Groin Lymph Nodes Trial in Worldwide (Inguinal Lymphadenectomy, Ilio-inguinal Lymphadenectomy)
Active, not recruiting
- Metastatic Melanoma to the Groin Lymph Nodes
- Inguinal Lymphadenectomy
- Ilio-inguinal Lymphadenectomy
-
Canberra, Australian Capital Territory, Australia
- +16 more
Apr 6, 2022
Developmental Dysplasia of the Hip Trial (Kirschner wire)
Not yet recruiting
- Developmental Dysplasia of the Hip
- Kirschner wire
- (no location specified)
Apr 20, 2023
Pancreas Cancer, Pancreatic Adenocarcinoma Trial in Verona (Systematic lymphadenectomy)
Recruiting
- Pancreas Cancer
- Pancreatic Adenocarcinoma
- Systematic lymphadenectomy
-
Verona, VR, ItalyUnit of Pancreatic Surgery - G.B. Rossi Hospital, University of
Nov 15, 2023
Lupus Nephritis Trial in Worldwide (Mycophenolate Mofetil/Mycophenolic Acid, Obinutuzumab, Placebo)
Active, not recruiting
- Lupus Nephritis
- Mycophenolate Mofetil/Mycophenolic Acid
- +4 more
-
La Jolla, California
- +45 more
Nov 14, 2022
Mycophenolate Mofetil, Cyclophosphamide, Lupus Nephritis Trial in Changsha (Cyclophosphamide, Mycophenolate Mofetil)
Recruiting
- Mycophenolate Mofetil
- +2 more
- Cyclophosphamide
- Mycophenolate Mofetil
-
Changsha, Hunan, Chinathe Second Xiangya Hospital of Central South University
Aug 8, 2022
Optimal Bowel Resection Extent and Central Radicality for Colon
Active, not recruiting
- Colon Cancer
-
Erlangen, Bayern, Germany
- +35 more
Jul 5, 2022
Lupus Nephritis, Chronic Kidney Diseases Trial in Hong Kong (Dapagliflozin 10mg Tab, Standard maintenance therapy)
Not yet recruiting
- Lupus Nephritis
- Chronic Kidney Diseases
- Dapagliflozin 10mg Tab
- Standard maintenance therapy
-
Hong Kong, Hong KongQueen Mary Hospital
Nov 24, 2023
Depression Trial in Worldwide (PReDicT Test, Treatment as Usual)
Completed
- Depression
- PReDicT Test
- Treatment as Usual
-
Paris, France
- +75 more
Mar 4, 2020
Lymphoma, Leukemia, Lymphocytic, Chronic, B-Cell Trial in Worldwide (Durvalumab, Lenalidomide, Rituximab)
Active, not recruiting
- Lymphoma
- Leukemia, Lymphocytic, Chronic, B-Cell
- Durvalumab
- +4 more
-
Gilbert, Arizona
- +53 more
Jan 25, 2022
Leukemia, Lymphocytic, Chronic, B-Cell Trial in Poland, Spain (Ibrutinib, OC: Ethinylestradiol (EE) 30 mcg and Levonorgestrel
Completed
- Leukemia, Lymphocytic, Chronic, B-Cell
- Ibrutinib
- +3 more
-
Krakow, Poland
- +3 more
Dec 3, 2019
Oxidative Stress Trial in Mumbai (LN-OS-22, Maltodextrin)
Recruiting
- Oxidative Stress
- LN-OS-22
- Maltodextrin
-
Mumbai, Maharashtra, India
- +1 more
Jun 17, 2022
Newly Diagnosed Multiple Myeloma Trial in Austria (Isatuximab-Irfc 20 MG/ML [Sarclisa], Lenalidomide, Dexamethasone Oral)
Recruiting
- Newly Diagnosed Multiple Myeloma
- Isatuximab-Irfc 20 MG/ML [Sarclisa]
- +2 more
-
Innsbruck, Tirol, Austria
- +15 more
Aug 24, 2022
Urinary T Cell Biomarker for Prediction in Lupus Nephritis
Active, not recruiting
- Lupus Nephritis
- Flow cytometry analysis of urine samples
-
Berlin, Germany
- +1 more
Mar 8, 2022
Kidney Transplantation, Graft Rejection, Immunosuppression Trial in United Kingdom (Rituximab, Control arm)
Completed
- Kidney Transplantation
- +2 more
- Rituximab
- Control arm
-
Birmingham, United Kingdom
- +10 more
Mar 3, 2020